Are Medical Stocks Lagging BioLife Solutions (BLFS) This Year?

Group 1 - BioLife Solutions, Inc. (BLFS) has shown strong year-to-date performance, returning 56.7%, significantly outperforming the Medical sector average return of 12.1% [4] - The Zacks Consensus Estimate for BLFS's full-year earnings has increased by 18.1% over the past 90 days, indicating improving analyst sentiment and a positive earnings outlook [4] - BioLife Solutions, Inc. holds a Zacks Rank of 2 (Buy), suggesting it has characteristics favorable for outperforming the market in the near term [3] Group 2 - BioLife Solutions, Inc. is part of the Medical - Products industry, which consists of 88 stocks and currently ranks 65 in the Zacks Industry Rank, with an average gain of 15.9% this year [6] - In comparison, Sensus Healthcare, Inc. (SRTS), another stock in the Medical sector, has achieved a year-to-date return of 159.3% and has a Zacks Rank of 2 (Buy) [5] - The Medical - Instruments industry, which includes Sensus Healthcare, has returned +10.2% since the beginning of the year and consists of 85 stocks, currently ranked 63 [7]